medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 1

<< Back Next >>

Med Int Mex 2023; 39 (1)

Omicron variant and the immune scape

Cabrera-Rayo A
Full text How to cite this article

Language: Spanish
References: 9
Page: 167-169
PDF size: 187.38 Kb.


Key words:

SARS-CoV-2, COVID-19, Vaccines.

ABSTRACT

The incidence of the omicron variant of SARS-CoV-2 has increased rapidly around the entire planet, even in vaccinated people. Sequencing results indicated that they were all from a new and genetically distinct lineage of SARS-CoV-2. This lineage was designated variant of concern and named omicron on the recommendation of the Technical Advisory Group on SARS-CoV-2. The main predominant subvariants in Mexico, the reasons for the immune escape and the current proposal to contain SARS-CoV-2 are presented.


REFERENCES

  1. Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C,Althaus CL, Anyaneji UJ, Bester PA, Boni MF, Chand M,Choga WT, Colquhoun R, Davids M, Deforche K, DoolabhD, du Plessis L, Engelbrecht S, Everatt J, Giandhari J, GiovanettiM, Hardie D, Hill V, Hsiao NY, Iranzadeh A, IsmailA, Joseph C, Joseph R, Koopile L, Kosakovsky Pond SL,Kraemer MUG, Kuate-Lere L, Laguda-Akingba O, Lesetedi-Mafoko O, Lessells RJ, Lockman S, Lucaci AG, MaharajA, Mahlangu B, Maponga T, Mahlakwane K, Makatini Z,Marais G, Maruapula D, Masupu K, Matshaba M, MayaphiS, Mbhele N, Mbulawa MB, Mendes A, Mlisana K, MnguniA, Mohale T, Moir M, Moruisi K, Mosepele M, Motsatsi G,Motswaledi MS, Mphoyakgosi T, Msomi N, Mwangi PN,Naidoo Y, Ntuli N, Nyaga M, Olubayo L, Pillay S, Radibe B,Ramphal Y, Ramphal U, San JE, Scott L, Shapiro R, SinghL, Smith-Lawrence P, Stevens W, Strydom A, SubramoneyK, Tebeila N, Tshiabuila D, Tsui J, van Wyk S, Weaver S,Wibmer CK, Wilkinson E, Wolter N, Zarebski AE, Zuze B,Goedhals D, Preiser W, Treurnicht F, Venter M, WilliamsonC, Pybus OG, Bhiman J, Glass A, Martin DP, Rambaut A,Gaseitsiwe S, von Gottberg A, de Oliveira T. Rapid epidemicexpansion of the SARS-CoV-2 Omicron variant in southernAfrica. Nature 2022; 603 (7902): 679-686. doi: 10.1038/s41586-022-04411-y.

  2. FDA. TaqPath SARSCOV-2. [Emergency Use Authorization].[2020]. Disponible en: https://www.fda.gov/media/136112/download

  3. Volz E, Mishra S, Chand M, Barrett J, et al. Assessing transmissibilityof SARS-CoV-2 lineage B.1.1.7 in England. Nature2021; 593: 266-269. doi: 10.1038/s41586-021-03470-x.

  4. Rambaut A, Holmes EC, O’Toole A, Hill V, et al. A dynamicnomenclature proposal for SARS-CoV-2 lineages to assistgenomic epidemiology. Nat Microbiol 2020; 5: 1403-1407.https://doi.org/10.1038/s41564-020-0770-5.

  5. WHO. Classification of Omicron (B.1.1.529): SARS-CoV-2Variant of Concern; https://www.who.int/news-room/statements/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern (2021).

  6. https://www.gisaid.org/.

  7. Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, FonsecaV, Giandhari J, Doolabh D, Pillay S, San EJ, MsomiN, Mlisana K, von Gottberg A, Walaza S, Allam M, IsmailA, Mohale T, Glass AJ, Engelbrecht S, Van Zyl G, PreiserW, Petruccione F, Sigal A, Hardie D, Marais G, Hsiao NY,Korsman S, Davies MA, Tyers L, Mudau I, York D, Maslo C,Goedhals D, Abrahams S, Laguda-Akingba O, Alisoltani-Dehkordi A, Godzik A, Wibmer CK, Sewell BT, LourençoJ, Alcantara LCJ, Kosakovsky Pond SL, Weaver S, MartinD, Lessells RJ, Bhiman JN, Williamson C, de Oliveira T.Detection of a SARS-CoV-2 variant of concern in SouthAfrica. Nature 2021; 592 (7854): 438-443. doi: 10.1038/s41586-021-03402-9.

  8. Marjorie R, Bondzie EA, Surve N, Hall K, Barouch DH,Neutralization escape by SARS-CoV-2 Omicron subvariantsBA.2.12.1, BA.4, and BA.5. N Engl J Med 2022; 386: 2526-2528.DOI: 10.1056/NEJMc2206725.

  9. Nohynek H, Wilder-Smith A. Does the world still need newCovid-19 vaccines? N Engl J Med 2022; 386: 2140-2142DOI: 10.1056/NEJMe2204695.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2023;39